1 min read

Webinar | Reducing Study Build Time from Weeks to Days

View Webinar On-Demand

VIEW ON-DEMAND

Rapid Database Build for COVID-19 Study Start-Up

Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.

Join Veristat and IBM Watson Health to learn how they were able to start up their COVID-19 trial in just 5 days and post-go-live protocol amendments in just 3 days.

The discussion will focus on how Veristat used specific IBM Clinical Development features  to achieve these results for the rapid start of a COVID-19 trial.


 

Attend the Complimentary  Webinar On-Demand:

Title:  Veristat Reduces Study Build Time from Weeks to Days with IBM Clinical Development

Date: Thursday, October 08, 2020 (Original Live Date)

Time: 11:00 AM Eastern Daylight Time

Duration: 45 minutes

(You will be brought to the IBM page to register for the download)

VIEW ON-DEMAND

 


 

Meet the Speakers:

 

Ryad RamdaRyad Ramda
Associate Director, Data Management
Veristat
 

 
Walker Bradham
Walker Bradham
Offering Manager, IBM Clinical Development
IBM Watson Health

 

 

Register for the Webinar Now: 

(You will be brought to the IBM registration page to download)

VIEW ON-DEMAND

 

Share This Event:

   

1 min read

Fierce Biotech Summit 2024

Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts

We...

4 min read

Unique Challenges in Recruiting Patients for Rare Indication Pediatric Studies: Overcoming Difficulties through a Site and CRO Perspective

Don't miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Barcelona, Thursday, October 24th...